These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 19588397)
21. Disappearance of soft drusen and subsequent development of choroidal neovascularization following macular hole surgery: a case report. Lee JH; Lee T; Lee SC; Lee CS BMC Ophthalmol; 2015 Apr; 15():43. PubMed ID: 25928705 [TBL] [Abstract][Full Text] [Related]
22. Submacular surgery for choroidal neovascularisation secondary to age-related macular degeneration. Giansanti F; Eandi CM; Virgili G Cochrane Database Syst Rev; 2009 Apr; (2):CD006931. PubMed ID: 19370663 [TBL] [Abstract][Full Text] [Related]
23. Risk factors for choroidal neovascularization and geographic atrophy in the complications of age-related macular degeneration prevention trial. Complications of Age-related Macular Degeneration Prevention Trial (CAPT) Research Group Ophthalmology; 2008 Sep; 115(9):1474-9, 1479.e1-6. PubMed ID: 18502512 [TBL] [Abstract][Full Text] [Related]
24. Laser-induced drusen reduction improves visual function at 1 year. Choroidal Neovascularization Prevention Trial Research Group. Ho AC; Maguire MG; Yoken J; Lee MS; Shin DS; Javornik NB; Fine SL Ophthalmology; 1999 Jul; 106(7):1367-73; discussion 1374. PubMed ID: 10406624 [TBL] [Abstract][Full Text] [Related]
25. Laser treatment in eyes with drusen. Ho AC Curr Opin Ophthalmol; 1999 Jun; 10(3):204-8. PubMed ID: 10537780 [TBL] [Abstract][Full Text] [Related]
26. Age-related macular degeneration: epidemiology and optimal treatment. la Cour M; Kiilgaard JF; Nissen MH Drugs Aging; 2002; 19(2):101-33. PubMed ID: 11950377 [TBL] [Abstract][Full Text] [Related]
27. Risk factors for choroidal neovascularization in the second eye of patients with juxtafoveal or subfoveal choroidal neovascularization secondary to age-related macular degeneration. Macular Photocoagulation Study Group. Arch Ophthalmol; 1997 Jun; 115(6):741-7. PubMed ID: 9194725 [TBL] [Abstract][Full Text] [Related]
28. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Evans JR; Lawrenson JG Cochrane Database Syst Rev; 2012 Nov; 11():CD000254. PubMed ID: 23152201 [TBL] [Abstract][Full Text] [Related]
32. Laser treatment in fellow eyes with large drusen: updated findings from a pilot randomized clinical trial. Choroidal Neovascularization Prevention Trial Research Group Ophthalmology; 2003 May; 110(5):971-8. PubMed ID: 12750100 [TBL] [Abstract][Full Text] [Related]
33. Statin use and the incidence of advanced age-related macular degeneration in the Complications of Age-related Macular Degeneration Prevention Trial. Maguire MG; Ying GS; McCannel CA; Liu C; Dai Y; Ophthalmology; 2009 Dec; 116(12):2381-5. PubMed ID: 19850347 [TBL] [Abstract][Full Text] [Related]
37. [Prophylactic laser treatment to macular soft drusen in age-related maculopathy of updated results]. Huang YX; Xiang LN; Wang YL; Gao LX; Hu YX Zhonghua Yan Ke Za Zhi; 2008 Nov; 44(11):1002-6. PubMed ID: 19176096 [TBL] [Abstract][Full Text] [Related]
38. [Age-related Macular Degeneration in the Japanese]. Yoshimura N Nippon Ganka Gakkai Zasshi; 2016 Mar; 120(3):163-88; discussion 189. PubMed ID: 27164756 [TBL] [Abstract][Full Text] [Related]
39. Risk factors for choroidal neovascularization and vision loss in the fellow eye study of CNVPT. Prenner JL; Rosenblatt BJ; Tolentino MJ; Ying GS; Javornik NB; Maguire MG; Ho AC; Retina; 2003 Jun; 23(3):307-14. PubMed ID: 12824829 [TBL] [Abstract][Full Text] [Related]